Drug class
Otic Antibiotics
Otic antibiotics are a route-specific therapeutic class of topical antimicrobial formulations administered directly into the ear canal to treat localized bacterial infections. Read more about Otic Antibiotics
57 drugs in this class 31 manufacturers
Drugs in Otic Antibiotics
CIPROFLOXACIN-DEXAMETHASONE (ciprofloxacin HCl/dexamethasone)
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL-FLUOCINOLONE (ciprofloxacin HCl/fluocinolone acetonide)
CIPROFLOXACIN-DEXAMETHASONE (ciprofloxacin HCl/dexamethasone)
OFLOXACIN
CETRAXAL (ciprofloxacin HCl)
OTOVEL (ciprofloxacin HCl/fluocinolone acetonide)
CIPRO HC (ciprofloxacin HCl/hydrocortisone)
Otic antibiotics are a route-specific therapeutic class of topical antimicrobial formulations administered directly into the ear canal to treat localized bacterial infections.
They primarily function by delivering high local concentrations of antibacterial agents—such as fluoroquinolones (e.g., ciprofloxacin, ofloxacin) or aminoglycoside and polypeptide combinations (e.g., neomycin and polymyxin B)—to inhibit bacterial DNA synthesis, protein production, or cell membrane integrity, frequently co-formulated with corticosteroids to suppress local inflammation.
Clinically, this drug class is indicated for the treatment of acute otitis externa and, in non-ototoxic formulations, acute otitis media in patients with tympanostomy tubes or chronic suppurative otitis media with perforated tympanic membranes.
-
fda.gov
Otic antibiotics are a route-specific therapeutic class of topical antimicrobial formulations administered directly into the ear canal to treat localized bacterial infections Clinically, this drug class is indicated for the treatment of acute otitis externa and, in non-ototoxic formulations, acute otitis media in patients with tympanostomy tubes or chronic suppurative otitis media with perforated tympanic membranes
-
nih.gov
Otic antibiotics are a route-specific therapeutic class of topical antimicrobial formulations administered directly into the ear canal to treat localized bacterial infections They primarily function by delivering high local concentrations of antibacterial agents—such as fluoroquinolones (e.g., ciprofloxacin, ofloxacin) or aminoglycoside and polypeptide combinations (e.g., neomycin and polymyxin B)—to inhibit bacterial DNA synthesis, protein production, or cell membrane integrity, frequently co-f...
-
fda.gov
They primarily function by delivering high local concentrations of antibacterial agents—such as fluoroquinolones (e.g., ciprofloxacin, ofloxacin) or aminoglycoside and polypeptide combinations (e.g., neomycin and polymyxin B)—to inhibit bacterial DNA synthesis, protein production, or cell membrane integrity, frequently co-formulated with corticosteroids to suppress local inflammation
-
fda.gov
They primarily function by delivering high local concentrations of antibacterial agents—such as fluoroquinolones (e.g., ciprofloxacin, ofloxacin) or aminoglycoside and polypeptide combinations (e.g., neomycin and polymyxin B)—to inhibit bacterial DNA synthesis, protein production, or cell membrane integrity, frequently co-formulated with corticosteroids to suppress local inflammation
-
nih.gov
Clinically, this drug class is indicated for the treatment of acute otitis externa and, in non-ototoxic formulations, acute otitis media in patients with tympanostomy tubes or chronic suppurative otitis media with perforated tympanic membranes
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.